I. Institutional Matters
II. On the Board and Offices
III. On Financial and Operational Matters
IV. On Governance Matters
V. Corporate Social Resposibility
I. Institutional Matters
- PPPI Legal Basis
- SEC Certificate of Filing of Amended Articles of Incorporation (change of name and amending the primary and secondary purpose of the corporation)
- SEC Certificate of Amended By-Laws issued on 09 November 2005
- SEC Certificate of Filing of Amended Articles of Incorporation (increase in capitalization)
- SEC Certificate of Increase of Capital Stocks
- SEC Certificate of Filing of Amended Articles of Incorporation (change of name and amending the primary purpose of the corporation)
- SEC Certificate of Amended By-Laws issued on 26 November 2015
- Executive Order No. 649-A – transferring PPI to DOH from OP
- Executive Order No. 54 – transferring PPI to DTI from DOH
- Company background and SEC General Information Sheet
- Parent Company and Affiliate
The Philippine Pharma Procurement, Inc. is a subsidiary of the Philippine International Trading Corporation and an affiliate of the National Development Company.
4. Government Corporate Information Sheet (GCIS), as mandated by the GCG in its Memorandum Circular No. 2012 – 01
II. On the Board and Offices
- Complete List of Directors and Officers
- The Complete compensation package of all board members and officers, including travel, representation and any other form of expenses of allowances
- Information on Board Committees
- Attendance Record of Directors in Board Meetings
III. On Financial and Operational Matters
- Annual Audit Reports (AARs)
- Quarterly Financial Reports and Trial Balance
2023
- 1st Quarter 2023 Financial Reports and Trial Balance
- 2nd Quarter 2023 Financial Reports and Trial Balance
- 3rd Quarter 2023 Financial Reports and Trial Balance
- 4th Quarter 2023 Financial Reports and Trial Balance
2022
- 1st Quarter 2022 Financial Reports and Trial Balance
- 2nd Quarter 2022 Financial Reports and Trial Balance
- 3rd Quarter 2022 Financial Reports and Trial Balance
- 4th Quarter 2022 Financial Reports and Trial Balance
3. Board Approved Corporate Operating Budget
- Local and Foreign Borrowing(Not Applicable)
- Government Subsidies and Net Lending(Not Applicable)
- Borrowing Guaranteed by the Government(Not Applicable)
- Material Risk Factors and Measures to Manage Such Risk
- Performance Evaluation System
IV. On Governance Matters
- Charter Statement
- Strategy Map and Performance Scorecard
- Organizational Chart
- Manual of Corporate Governance
- Corporate Social Responsibility statement
- Balanced Scorecard
- No Gift Policy
- Code of Conduct for PPPI Officers and Employees
- Statement of No Audit Suspensions, Disallowances and Charges (SASDC)
j. Agency Action Plan and Status of Implementation on COA AOM
V. Corporate Social Resposibility